Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Magalie Pascale Tardy"'
Autor:
Cédric Rossi, Kamel Laribi, Alexandra Traverse-Glehen, Fabrice Jardin, Roch Houot, Alexandre Willaume, Martin Gauthier, Sophie Bernard, David Tonnelet, Katell Le Du, Gandhi Damaj, Pierre Sesques, Magalie Pascale Tardy, Julien Lazarovici, Hélène Monjanel, Hervé Tilly, Laure Lebras, Corinne Haioun, Adrien Chauchet, Chloe Antier, Alina Berriolo-Riedinger, Caroline Besson, Herve Gerard Maisonneuve, Vincent Camus, Christophe Bonnet, Justine Lequesne, Eric Durot, Sylvain Choquet, Stéphanie Becker, Sarah Bailly, Marie-Pierre Moles-Moreau, Pierre Decazes
Publikováno v:
Blood Adv
Blood advances, Vol. 5, no. 19, p. 3862-3872 (2021)
Blood advances, Vol. 5, no. 19, p. 3862-3872 (2021)
Primary mediastinal B-cell lymphoma (PMBL) is a rare type of aggressive lymphoma typically affecting young female patients. The first-line standard of care remains debated. We performed a large multicenter retrospective study in 25 centers in France
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02aae272ce0ecca7c91653bb98154697
https://europepmc.org/articles/PMC8679665/
https://europepmc.org/articles/PMC8679665/
Autor:
Cécile Badoual, Anne Sudaka-Bahadoran, Alexandre Bozec, Magalie Pascale Tardy, Ilaria Di Mauro, Florence Pedeutour, Sadal Refae, Esma Saada-Bouzid, Nathalie Ebran, Karen Benezery, Joël Guigay, Frederic Peyrade
Publikováno v:
Oral Oncology. 80:104-107
Autor:
Laure Lebras, Kamel Laribi, Stéphanie Becker, Alina Berriolo-Riedinger, Marie-Pierre Moles, Hervé Tilly, Christophe Bonnet, Roch Houot, Alexandre Willaume, Hélène Monjanel, Eric Durot, Pierre Decazes, Pierre Sesques, Julien Lazarovici, Adrien Chauchet, Sophie Bernard, Damaj Gandhi Laurent, Martin Gauthier, Fabrice Jardin, Magalie Pascale Tardy, Chloe Antier, Choquet Sylvain, Caroline Besson, David Tonnelet, Corinne Haioun, Cédric Rossi, Hervé Maisonneuve, J. Lequesne, Sarah Bailly, Katell Le Du, Vincent Camus
Publikováno v:
Blood. 136:20-21
Introduction: Primary mediastinal B cell lymphoma (PMBL) is clinically and biologically distinct from the other subtypes of diffuse large B cell lymphoma (DLBCL), typically affecting young female patients (pts) with a bulky mediastinal mass. Standard
Autor:
Marion Rolland, Guilhem Roubaud, Sara Faouzi, Damien Pouessel, Brigitte Laguerre, Magalie Pascale Tardy, Marine Gross-Goupil, Clement Dumont, Ludovic Doucet, Hakim Mahammedi, Christine Chevreau, Aude Flechon, Lionnel Geoffrois, Mathilde Guerin, Leonor Chaltiel, Diego Tosi, Karim Fizazi, Stéphane Oudard
Publikováno v:
Journal of Clinical Oncology. 39:385-385
385 Background: Personalized chemotherapy based on tumor marker decline is the new standard in poor prognosis germ-cell tumor in Europe since 2014 (GETUG 13, Lancet, Fizazi et al). The purpose of this study was to analyze the reproducibility of the p
Autor:
Mihaela Aldea, Bruno Vincenzi, Franco Morelli, Magalie Pascale Tardy, Christoph Oing, Sylvain Ladoire, Stéphanie Foulon, Simona Secondino, Karim Fizazi, Giulia Baciarello, Damien Pouessel, Laurence Crouzet, Ugo De Giorgi, Caroline Brard
Publikováno v:
Journal of Clinical Oncology. 38:420-420
420 Background: Only scarce data exist on the management of residual masses in men who have received two lines of chemotherapy for advanced seminoma. Due to the lack of data, the role of PET scanning, surgery and other additional treatments is contro
Autor:
Frederic Peyrade, Magalie Pascale Tardy, Lauris Gastaud, Annick Boscagli, Andrea Gallamini, Antoine Thyss
Publikováno v:
Hematological Oncology. 35:875-877
The patients with refractory Hodgkin lymphoma have a poor prognosis. The nivolumab, an IgG4 monoclonal antibody inhibiting the program death 1 pathway has recently demonstrated its efficacy and its safety in patients with heavily pretreated refractor
Autor:
Simone Mathoulin-Pélissier, Laurence Bozec Lemoal, Caroline Lalet, Magalie Pascale Tardy, Esma Saada, Emilie Toulza, Agnès Ducoulombier, Antoine Italiano, Romain Desgrippes, Elena Paillaud, Coriolan Lebreton, Coralie Cantarel
Publikováno v:
Journal of Clinical Oncology. 37:11550-11550
11550 Background: It is crucial that targeted therapies are also studied in senior patients to establish predictive factors of severe toxicity. Methods: The PRETOXE study includes 3 multicentric independent cohorts of patients ≥70 years old with ad
Autor:
Maria Kogay, Regis Kaphan, Magalie Pascale Tardy, Frederic Peyrade, Anne-Marie Stoppa, Jérôme Doyen, Jean Gutnecht, Daniel Re, Valentine Richez, Marie-Christine Etienne-Grimaldi, Borhane Slama, Annick Boscagli
Publikováno v:
Journal of Clinical Oncology. 36:e20035-e20035
e20035Background: Rd is a treatment option for patients (pts) ineligible for transplant. Lenalidomide (R) pharmacokinetics (PK) has been evaluated in pts under 65 and very few data are available ab...
Autor:
Jean Gutnecht, Magalie Pascale Tardy, Annick Boscagli, Richard Skaf, Salvatore Caruso, Antoine Thyss, Mario Ojeda-Uribe, Frederic Peyrade, Lauris Gastaud
Publikováno v:
Experimental Hematology & Oncology
Background Refractory or relapsed large B-cells lymphoma are usually treated with a high dose chemotherapy regimen followed by an autolougous stem cells transplantation. BEAM (carmustine, etoposide, cytarabine, melphalan) or more recently Z-BEAM (ibr
Autor:
Frederic Peyrade, Amaury Daste, Victor Sarradin, Alexandre Bozec, Martin Lange, Mathilde Saint-Ghislain, Magalie Pascale Tardy, Celine Lescure, Jérôme Doyen, G. Lefebvre, Esma Saada-Bouzid
Publikováno v:
Journal of Clinical Oncology. 35:e17524-e17524
e17524 Background: Standard treatment for first line RM HNSCC is the association of platinum-5FU and cetuximab. For non-progressive patients (pts), cetuximab is given weekly as maintenance until progression or unacceptable toxicity. In the EXTREME pr